Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID85 | TVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2267.07 | MALDI-TOF | Metastatic thyroid carcinomas | NA | 16896061 |
| CancerPDF_ID86 | AATVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2409.13 | MALDI-TOF | Metastatic thyroid carcinomas | NA | 16896061 |
| CancerPDF_ID87 | AATVGSLAGQPLQERAQAWGERLR | Apolipoprotein E | Serum | 2565.45 | MALDI-TOF | Metastatic thyroid carcinomas | NA | 16896061 |
| CancerPDF_ID313 | KVEQAVETEPEPELRQQ | Apolipoprotein E | Plasma | 670.6713333 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID314 | KVEQAVETEPEPELR | Apolipoprotein E | Plasma | 585.299 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID315 | KVEQAVETEPEPEL | Apolipoprotein E | Plasma | 799.398 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID316 | VEQAVETEPEPELRQQ | Apolipoprotein E | Plasma | 627.973 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID317 | LVEKVQAAVGTSAAPVPSDNH | Apolipoprotein E | Plasma | 697.3626667 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID318 | KVQAAVGTSAAPVPSD | Apolipoprotein E | Plasma | 749.3955 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID319 | VQAAVGTSAAPVPSDNH | Apolipoprotein E | Plasma | 810.899 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID320 | QAAVGTSAAPVPSDNH | Apolipoprotein E | Plasma | 761.365 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID321 | AAVGTSAAPVPSDNH | Apolipoprotein E | Plasma | 697.3355 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID322 | AATVGSLAGQPLQER | Apolipoprotein E | Plasma | 749.4015 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID323 | TVGSLAGQPLQERAQAWGER | Apolipoprotein E | Plasma | 718.702 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID324 | TVGSLAGQPLQERAQAW | Apolipoprotein E | Plasma | 906.47 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID325 | TVGSLAGQPLQERAQ | Apolipoprotein E | Plasma | "777.91, 518.94" | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID326 | TVGSLAGQPLQERA | Apolipoprotein E | Plasma | 713.8825 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID327 | TVGSLAGQPLQER | Apolipoprotein E | Plasma | 678.364 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID328 | TVGSLAGQPL | Apolipoprotein E | Plasma | 471.763 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID329 | RLAVYQAGAREGAER | Apolipoprotein E | Plasma | 549.6243333 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID330 | LAVYQAGAREGAER | Apolipoprotein E | Plasma | 497.5906667 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID331 | LGPLVEQGR | Apolipoprotein E | Plasma | 484.7765 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID332 | SWFEPLVEDMQR | Apolipoprotein E | Plasma | 768.858 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID1083 | TVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2267.07 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1084 | AATVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2409.13 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =97, 2124 and 109 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1085 | AATVGSLAGQPLQERAQAWGERLR | Apolipoprotein E | Serum | 2565.45 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1, 902 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1687 | GPLVEQGRVR | Apolipoprotein E | Serum | 1109.63054 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1688 | KVEQAVETEPEPELR | Apolipoprotein E | Serum | 1752.88939 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1689 | AATVGSLAGQPLQER | Apolipoprotein E | Serum | 1496.79471 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1690 | VQAAVGTSAAPVPSDNH | Apolipoprotein E | Serum | 1619.79035 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1691 | SELEEQLTPVAEETR | Apolipoprotein E | Serum | 1729.83702 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1692 | AATVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2408.25606 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1693 | AATVGSLAGQPLQERAQAWGERLR | Apolipoprotein E | Serum | 2564.35717 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1694 | VEQAVETEPEPELR | Apolipoprotein E | Serum | 1624.79443 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1695 | TVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2266.18183 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1696 | LGPLVEQGRV | Apolipoprotein E | Serum | 1066.61349 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1697 | RLAVYQAGAREGAER | Apolipoprotein E | Serum | 1645.86485 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1698 | GEVQAMLGQSTEELR | Apolipoprotein E | Serum | 1646.79338 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1699 | SELEEQLTPVAEETRA | Apolipoprotein E | Serum | 1800.87414 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1700 | AATVGSLAGQPLQERAQAWGER | Apolipoprotein E | Serum | 2295.17199 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1701 | LGPLVEQGR | Apolipoprotein E | Serum | 967.54508 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1702 | RLSKELQAAQAR | Apolipoprotein E | Serum | 1369.779 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1703 | ATVGSLAGQPLQER | Apolipoprotein E | Serum | 1425.75759 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1704 | AYKSELEEQLTPVAEET | Apolipoprotein E | Serum | 1935.93132 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1705 | AYKSELEEQLTPVAEETR | Apolipoprotein E | Serum | 2092.03243 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1706 | SELEEQLTPVAEET | Apolipoprotein E | Serum | 1573.73591 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1707 | KVEQAVETEPEPEL | Apolipoprotein E | Serum | 1596.78828 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1708 | GLSAIRERLGPLVEQGR | Apolipoprotein E | Serum | 1850.04863 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1709 | GRLVQYRGEVQAMLGQSTEELRV | Apolipoprotein E | Serum | 2618.35987 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2953 | AQAWGERL | Apolipoprotein E | Plasma | 929.4719 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2954 | MEEMGSRT | Apolipoprotein E | Plasma | 939.379 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2955 | LGPLVEQGRV | Apolipoprotein E | Plasma | 1066.6135 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2956 | LGPLVEQGRVR | Apolipoprotein E | Plasma | 1222.7146 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2957 | ARLSKELQAAQA | Apolipoprotein E | Plasma | 1284.715 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2958 | ALMDETMKELK | Apolipoprotein E | Plasma | 1307.6465 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2959 | ARLSKELQAAQAR | Apolipoprotein E | Plasma | 1440.8161 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2960 | EGAERGLSAIRER | Apolipoprotein E | Plasma | 1442.759 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2961 | LAVYQAGAREGAER | Apolipoprotein E | Plasma | 1489.7637 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2962 | AATVGSLAGQPLQER | Apolipoprotein E | Plasma | 1496.7947 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2963 | SELEEQLTPVAEET | Apolipoprotein E | Plasma | 1573.7359 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2964 | KVEQAVETEPEPEL | Apolipoprotein E | Plasma | 1596.7883 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2965 | VQAAVGTSAAPVPSDNH | Apolipoprotein E | Plasma | 1619.7904 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2966 | RLAVYQAGAREGAER | Apolipoprotein E | Plasma | 1645.8648 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2967 | DRLDEVKEQVAEVR | Apolipoprotein E | Plasma | 1684.8744 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2968 | SELEEQLTPVAEETR | Apolipoprotein E | Plasma | 1729.837 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2969 | KVEQAVETEPEPELR | Apolipoprotein E | Plasma | 1752.8894 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2970 | TRDRLDEVKEQVAEV | Apolipoprotein E | Plasma | 1785.9221 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2971 | SELEEQLTPVAEETRA | Apolipoprotein E | Plasma | 1800.8741 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2972 | AYKSELEEQLTPVAEET | Apolipoprotein E | Plasma | 1935.9313 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2973 | GLSAIRERLGPLVEQGRV | Apolipoprotein E | Plasma | 1949.117 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2974 | AATVGSLAGQPLQERAQAWGER | Apolipoprotein E | Plasma | 2295.172 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2975 | AATVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Plasma | 2408.2561 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID2976 | AATVGSLAGQPLQERAQAWGERLR | Apolipoprotein E | Plasma | 2564.3572 | LC-MS | Normal | NA | 21136997 |
| CancerPDF_ID3559 | VGTSAAPVPSDNH | Apolipoprotein E | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID4825 | FEPLVEDMQRQWAGL | Apolipoprotein E | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4826 | FEPLVEDMQRQWAGLVEKV | Apolipoprotein E | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8679 | ADMEDVCGRLV | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8680 | ADMEDVCGRLVQ | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8721 | AVETEPEPEL | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8722 | AVETEPEPELRQ | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8723 | AVETEPEPELRQQ | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8763 | DMEDVCGRLV | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8807 | EQAVETEPEPEL | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9006 | KVEQAVETEPEP | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9017 | LGADMEDVCGRLV | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9150 | QAVETEPEPELR | Apolipoprotein E | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9578 | VGSLAGQPLQERA | Apolipoprotein E | Serum | 663.36 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9579 | TVGSLAGQPLQER | Apolipoprotein E | Serum | 678.36 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9580 | TVGSLAGQPLQERA | Apolipoprotein E | Serum | 713.86 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9581 | KVEQAVETEPEPEL | Apolipoprotein E | Serum | 799.37 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9582 | TVGSLAGQPLQERAQA | Apolipoprotein E | Serum | 813.41 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9583 | TVGSLAGQPLQERAQAWGE | Apolipoprotein E | Serum | 999.51 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9584 | KVEQAVETEPEPELRQQ | Apolipoprotein E | Serum | 670.66 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9585 | TVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 756.38 | LC-MS | Lung adenocarcinoma | Differentially expressed between Lung cancer vs control | 21533267 |
| CancerPDF_ID9586 | AATVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 803.76 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID11871 | KVEQAVETE | Apolipoprotein E | Serum | 1031.5135 | LC-MS | Melanoma | "Present in 6 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |